CRITICAL APPRAISAL SERIES
Critical appraisal for emergency medicine 3: Evaluation of a therapy
Correspondence to:
Professor S Goodacre, Medical Care Research Unit, University of Sheffield, Regent Court, 30 Regent Street, Sheffield S1 4DA, UK; s.goodacre@sheffield.ac.uk
Accepted 6 January 2008
| The first 150 words of the full text of this article appear below. |
Evaluation of a therapy involves comparing a group of patients receiving the intervention with a group of patients who do not receive it (the control group). With a few rare exceptions (such as diseases that currently have 100% mortality), a control group is always required to demonstrate that any improvement observed after treatment is not simply due to the natural course of the illness. There are a number of key elements in the design of these studies that will determine whether the findings are valid and generalisable.
SELECTION AND ALLOCATION OF STUDY PARTICIPANTS
Patients are selected to a trial by a process of recruitment that usually involves identification of potential participants, assessment of eligibility using inclusion and exclusion criteria, followed by a request for consent to participate. Selection can occur at any of these stages to influence the constitution of the study population. This is obviously a necessary process in assembling the study population, but selection
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
